Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: Views over hidden possibilities

AIDS Research and Therapy

Volumn 4, Issue , 2007, Pages

  Shankar, Esaki Muthu ^a   Vignesh, Ramachandran ^a   Murugavel, Kailapuri G ^a   Balakrishnan, Pachamuthu ^a   Sekar, Ramalingam ^a   Lloyd, Charmaine A C ^a   Solomon, Suniti ^a   Kumarasamy, Nagalingeswaran ^a  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIUM LIPOPOLYSACCHARIDE; MYCOBACTERIUM ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL TRANSLOCATION; CD4+ T LYMPHOCYTE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; GENETIC ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT RESPONSE; TUBERCULOSIS;

EID: 38749101664     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-4-29     Document Type: Article

References (79)

1. Kumarasamy N Chaguturu S Mayer KH Solomon S Yepthomi HT Balakrishnan P Flanigan TP Incidence of immune reconstitution syndrome in HIV/ tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India J Acquir Immune Defic Syndr 2004, 37:1574-1576. 10.1097/00126334-200412150-00007 15577411
2. Keane NM Price P Lee S Almeida CA Stone SF James I French MA Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy HIV Med 2004, 5:407-414. 10.1111/ j.1468-1293.2004.00245.x 15544692
3. Stone SF Price P Brochier J French MA Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpes virus-associated immune restoration disease after start of highly active antiretroviral therapy J Infect Dis 2001, 184-1073. 1077 10.1086/323599 11574925
4. Koval CE Gigliotti F Nevins D Demeter LM Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection Clin Infect Dis 2002, 35(4):491-493. 10.1086/341974 12145736
5. Bicanic T Harrison T Niepieklo A Dyakopu N Meintjes G Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: The role of fluconazole resistance and immune reconstitution Clin Infect Dis 2006, 43:1069-1073. 10.1086/507895 16983622
6. Lawn SD Bicanic TA Macallan DC Pyomyositis and cutaneous abscesses due to Mycobacterium avium: An immune reconstitution manifestation in a patient with AIDS Clin Infect Dis 2004, 38:461-463. 10.1086/381033 14727228
7. Sereti I Sarlis NJ Arioglu E Turner ML Mican JM Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy AIDS 2001, 15:138-140. 10.1097/ 00002030-200101050-00026 11192862
8. Mirmirani P Maurer TA Herndier B McGrath M Weinstein MD Berger TG Sarcoidosis in a patient with AIDS: A manifestation of immune restoration syndrome J Am Acad Dermatol 1999, 41:285-286. 10.1016/ S0190-9622(99)70364-6 10426909
9. Lawn SD Checkley A Wansbrough-Jones MH Acute bilateral parotitis caused by Mycobacterium scrofulaceum: Immune reconstitution disease in a patient with AIDS Sex Transm Infect 2005, 81:517-518. 10.1136/ sti.2005.014993 16326858
10. Taylor CL Subbarao V Gayed S Ustianowski AP Immune reconstitution syndrome to Strongyloides stercoralis infection AIDS 2007, 21:649-650. 17314529
11. Kumarasamy N Vallabhaneni S Flanigan TP Mayer KH Solomon S Clinical profile of HIV in India Indian J Med Res 2005, 121:377-394. 15817951
12. Breton G Duval X Estellat C Poaletti X Bonnet D Mvondo MD Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy Clin Infect Dis 2004, 39:1709-1712. 10.1086/425742 15578375
13. Wendel KA Alwood KS Gachuhi R Chaisson RE Bishai WR Sterling TR Paradoxical worsening of tuberculosis in HIV infected persons Chest 2001, 120:193-197. 10.1378/chest.120.1.193 11451837
14. Shelburne SA Visnegarwala F Darcourt J Graviss EA Giordano TP White AC Jr Hamill RJ Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy AIDS 2005, 19:399-406. 10.1097/01.aids.0000161769.06158.8a 15750393
15. Shao H Crump J Ramadhani H Uiso L Sendui-Nguyaine Kiwera R Ndosil E Shao J Bartlett J Thielman N A randomised trial of early versus delayed fixed dose combination zidovudine/lamivudine/abacavir in patients coinfected with HIV and tuberculosis: Early findings of the tuberculosis and immune reconstitution syndrome trial Thirteenth Conference on Retroviruses and Opportunistic Infections. Denver, CO, February 2006 [abstract 796]
16. Shelburne SA Montes M Hamill RJ Immune reconstitution inflammatory syndrome: More answers, more questions J Antimicrob Chemother 2006, 57:167-170. 10.1093/jac/dki444 16354748
17. Bourgarit A Carcelain G Martinez V Lascoux C Delcey V Gicquel B Vicaut E Lagrange PH Sereni D Autran B Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients AIDS 2006, 20:F1-F7. 16511406
18. Race EM Adelson-Mitty J Kriegel GR Barlam TF Reimann KA Letvin NL Japour AJ Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease Lancet 1998, 351:252-255. 10.1016/S0140-6736(97)04352-3 9457095
19. Brenchley JM Schacker TW Ruff LE Price DA Taylor JH Beilman GJ Nguyen PL Khoruts A Larson M Haase AT Douek DC CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract J Exp Med 2004, 200:749-759. 10.1084/jem.20040874 15365096
20. Brenchley JM Price DA Douek DC HIV disease: Fallout from a mucosal catastrophe? Nat Immunol 2006, 7:235-239. 10.1038/ni1316 16482171
21. Brenchley JM Price DA Schacker TW Asher TE Silvestri G Rao S Kazzaz Z Bornstein E Lambotte O Altmann D Blazar BR Rodriguez B Teixeira-Johnson L Landay A Martin JN Hecht FM Picker LJ Lederman MM Deeks SG Douek DC Microbial translocation is a cause of systemic immune activation in chronic HIV infection Nat Med 2006, 12:1365-1371. 10.1038/nm1511 17115046
22. Mattapallil JJ Douek DC Hill B Nishimura Y Martin M Roederer M Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection Nature 2005, 434:1093-1097. 10.1038/nature03501 15793563
23. Veazey RS DeMaria M Chalifoux LV Shvetz DE Pauley DR Knight HL Rosenzweig M Johnson RP Desrosiers RC Lackner AA Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection Science 1998, 280:427-431. 10.1126/science.280.5362.427 9545219
24. Guadalupe M Reay E Sankaran S Prindiville T Flamm J McNeil A Dandekar S Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy J Virol 2003, 77:11708-11717. 229357 14557656 10.1128/JVI.77.21.11708-11717.2003
25. Picker LJ Hagen SI Lum R Reed-Inderbitzin EF Daly LM Sylwester AW Walker JM Siess DC Piatak M. Jr. Wang C. Allison D.B. Maino V.C. Lifson J.D. Kodama T. Axthelm M.K. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection J Exp Med 2004, 200:1299-1314. 10.1084/jem.20041049 15545355
26. Li Q Duan L Estes JD Ma ZM Rourke T Wang Y Reilly C Carlis J Miller CJ Haase AT Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells Nature 2005, 434:1148-1152. 15793562
27. Mehandru S Poles MA Tenner-Racz K Horowitz A Hurley A Hogan C Boden D Racz P Markowitz M Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract J Exp Med 2004, 200:761-770. 10.1084/jem.20041196 15365095
28. George MD Reay E Sankaran S Dandekar S Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration J Virol 2005, 79:2709-2719. 548479 15708990 10.1128/ JVI.79.5.2709-2719.2005
29. Kotler DP HIV infection and the gastrointestinal tract AIDS 2005, 19:107-117. 10.1097/00002030-200501280-00002 15668535
30. Sharpstone D Neild P Crane R Taylor C Hodgson C Sherwood R Gazzard B Bjarnason I Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea Gut 1999, 45:70-76. 1727572 10369707
31. Cooke KR Olkiewicz K Erickson N Ferrara JL The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease J Endotoxin Res 2002, 8:441-448. 12697087
32. Macpherson AJ Harris NL Interactions between commensal intestinal bacteria and the immune system Nat Rev Immunol 2004, 4:478-485. 10.1038/ nri1373 15173836
33. Takeda K Kaisho T Akira S Toll-like receptors Annu Rev Immunol 2003, 21:335-376. 10.1146/annurev.immunol.21.120601.141126 12524386
34. Schietroma M Carlei F Cappelli S Amicucci G Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy Ann Surg 2006, 243:359-363. 1448948 16495701 10.1097/ 01.sla.0000201455.89037.f6
35. Caradonna L Amati L Magrone T Pellegrino NM Jirillo E Caccavo D Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: Biological and clinical significance J Endotoxin Res 2000, 6:205-214. 11052175
36. Hill GR Teshima T Gerbitz A Pan L Cooke KR Brinson YS Crawford JM Ferrara JL Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia J Clin Invest 1999, 104:459-467. 408528 10449438
37. Schietroma M Cappelli S Carlei F Di Giuro G Agnifili A Recchia CL Antonellis M Amicucci G Intestinal and systemic endotoxaemia after laparotomic or laparoscopic cholecystectomy Chir Ital 2006, 58:171-177. 16734165
38. Wellmann W Fink PC Benner F Schmidt FW Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid Gut 1986, 27:814-820. 1433583 3732891 10.1136/gut.27.7.814
39. Wyatt J Vogelsang H Hubl W Waldhoer T Lochs H Intestinal permeability and the prediction of relapse in Crohn's disease Lancet 1993, 341:1437-1439. 10.1016/0140-6736(93)90882-H 8099141
40. Nicastri E Chiesi A Angeletti C Sarmati L Palmisano L Geraci A Andreoni M Vella S Italian Antiretroviral Treatment Group (IATG) Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART J Med Virol 2005, 76:153-160. 10.1002/jmv.20352 15834865
41. Douek DC Picker LJ Koup RA T cell dynamics in HIV-1 infection Annu Rev Immunol 2003, 21:265-304. 10.1146/annurev.immunol.21.120601.141053 12524385
42. Bower M Fox P Fife K Gill J Nelson M Gazzard B Highly active antiretroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma AIDS 1999, 13:2105-2111. 10.1097/ 00002030-199910220-00014 10546864
43. Chien J Johnson H Paradoxical reactions in HIV and pulmonary TB Chest 1998, 114:933-936. 9743188
44. Kunimoto DY Chui L Nobert E Houston S Immune mediated "HAART" attack during treatment for tuberculosis Int J Tuberc Lung Dis 1999, 3:944-947. 10524594
45. Shelburne SA III Hamill RJ Rodriguez-Barradas MC Greenberg SB Atmar RL Musher DW Gathe JC Jr Visnegarwala F Trautner BW Immune reconstitution inflammatory syndrome: Emergence of a unique syndrome during highly active antiretroviral therapy Medicine (Baltimore) 2002, 81:213-227. 10.1097/00005792-200205000-00005 11997718
46. Mitsuyasu R HIV protease inhibitors: Immunological insights AIDS 1999, 13(Suppl 1):S19-S27. 10546782
47. Narita M Ashkin D Hollender ES Pitchenik AE Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS Am J Respir Crit Care Med 1998, 158:157-161. 9655723
48. John M French MAH Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy Med J Aust 1998, 169:473-474. 9847899
49. Fishman JE Saraf-Lavi E Narita M Hollender ES Ramsinghani R Ashkin D Pulmonary tuberculosis in AIDS patients: Transient chest radiographic worsening after initiation of antiretroviral therapy AJR Am J Roentgenol 2000, 174:43-49. 10628452
50. Furrer H Malinverni R Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis Am J Med 1999, 106:371-372. 10.1016/ S0002-9343(99)00015-7 10190387
51. Stone SF Price P Brochier J French MA Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy J infect Dis 2001, 184:1073-1077. 10.1086/323599 11574925
52. Shahin RD Engberg I Hagberg L Eden CS Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection J Immunol 1987, 138:3475-3480. 3553327
53. Dadgostar H Zarnegar B Hoffmann A Qin XF Truong U Rao G Baltimore D Cheng G Cooperation of multiple signaling pathways in CD4+0-regulated gene expression in B lymphocytes Proc Natl Acad Sci USA 2002, 5:1497-1502. 10.1073/pnas.032665099
54. D'Acquisto F May MJ Ghosh S Inhibition of nuclear factor kappa B (NFkB): an emerging theme in anti-inflammatory therapies Molec Interv 2002, 2:22-35. 10.1124/mi.2.1.22
55. Seaman DR Joint complex dysfunction, a novel term to replace subluxation/ subluxation complex: Etiological and treatment considerations J Manipulative Physiol Ther 1997, 20:634-644. 9436150
56. Seaman DR The diet-induced proinflammatory state: A cause of chronic pain and other degenerative diseases? J Manipulative Physiol Ther 2002, 25:168-179. 10.1067/mmt.2002.122324 11986578
57. van der Poll T de Wall Malefyt R Coyle SM Lowry SF Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13 J Infect Dis 1997, 175:118-122. 8985204
58. Zimmer S Pollard V Marshall GD Effects of endotoxin on the Th1/Th2 response in humans J Burn Care Rehabil 1996, 17:491-496. 10.1097/ 00004630-199611000-00004 8951535
59. Lauw FN Lauw FN ten Hove T Dekkers PE de Jonge E van Deventer SJ van Der Poll T Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin Infect Immun 2000, 68:1014-1018. 97242 10678901 10.1128/IAI.68.3.1014-1018.2000
60. Olszyna DP Pajkrt D van Deventer SJ van der Poll T Effect of interleukin 10 on the release of the CXC chemokines growth related oncogene GRO-alpha and epithelial cell-derived neutrophil activating peptide (ENA)-78 during human endotoxemia Immunol Lett 2001, 78:41-44. 10.1016/ S0165-2478(01)00224-3 11470150
61. Olszyna DP Pajkrt D Lauw FN van Deventer SJ van Der Poll T Interleukin 10 inhibits the release of CC chemokines during human endotoxemia J Infect Dis 2000, 181:613-620. 10.1086/315275 10669345
62. West MA Heagy W Endotoxin tolerance: A review Crit Care Med 2002, 30:S64-S73. 10.1097/00003246-200201001-00009
63. Dobrovolskaia MA Vogel SN Toll receptors, CD14, and macrophage activation and deactivation by LPS Microbes Infect 2002, 4:903-914. 10.1016/S1286-4579(02)01613-1 12106783
64. Munoz C Carlet J Fitting C Misset B Blériot JP Cavaillon JM Dysregulation of in vitro cytokine production by monocytes during sepsis J Clin Invest 1991, 88:1747-1754. 295719 1939659
65. Volk HD Thieme M Heym S Döcke WD Ruppe U Tausch W Manger D Zuckermann S Golosubow A Nieter B Alterations in function and phenotype of monocytes from patients with septic disease: Predictive value and new therapeutic strategies Behring Inst Mitt 1991, 88:208-215. 2049040
66. Wilson CS Seatter SC Rodriguez JL Bellingham J Clair L West MA In vivo endotoxin tolerance: Impaired LPS-stimulated TNF release of monocytes from patients with sepsis, but not SIRS J Surg Res 1997, 69:101-106. 10.1006/jsre.1997.5040 9202654
67. Döcke WD Randow F Syrbe U Krausch D Asadullah K Reinke P Volk HD Kox W Monocyte deactivation in septic patients: Restoration by IFN-g treatment Nat Med 1997, 3:678-681. 10.1038/nm0697-678 9176497
68. Wolk K Docke WD von Baehr V Volk HD Sabat R Impaired antigen presentation by human monocytes during endotoxin tolerance Blood 2000, 96:218-223. 10891454
69. Adib-Conquy M Adrie C Moine P Asehnoune K Fitting C Pinsky MR Dhainaut JF Cavaillon JM NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance Am J Respir Crit Care Med 2000, 162:1877-1883. 11069829
70. Sugawara S Nemoto E Tada H Miyake K Imamura T Takada H Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness J Immunol 2000, 165:411-418. 10861079
71. Randow F Syrbe U Meisel C Krausch D Zuckermann H Platzer C Volk HD Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor beta J Exp Med 1995, 181:1887-1892. 10.1084/jem.181.5.1887 7722463
72. Park DR Skerrett SJ IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: Differential responses of blood monocytes and alveolar macrophages J Immunol 1996, 157:2528-2538. 8805654
73. Raychaudhuri B Fisher CJ Farver CF Malur A Drazba J Kavuru MS Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages Cytokine 2000, 12:1348-1355. 10.1006/cyto.2000.0721 10975994
74. Heagy W Hansen C Nieman K Cohen M Richardson C Rodriguez JL Thomassen MJ Impaired ex vivo lipopolysaccharide stimulated whole blood tumor necrosis factor production may identify "septic' intensive care unit patients Shock 2000, 14:271-276. 11028542
75. Nomura F Akashi S Sakao Y Sato S Kawai T Matsumoto M Nakanishi K Kimoto M Miyake K Takeda K Akira S Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression J Immunol 2000, 164:3476-3479. 10725699
76. Sato S Nomura F Kawai T Takeuchi O Mühlradt PF Takeda K Akira S Synergy and crosstolerance between toll-like receptor (TLR) 2- and TLR-4- mediated signaling pathways J Immunol 2000, 165:7096-7101. 11120839
77. Fahmi H Chaby R Desensitization of macrophages to endotoxin effects is not correlated with a down-regulation of lipopolysaccharide-binding sites Cell Immunol 1993, 150:219-229. 10.1006/cimm.1993.1191 7688269
78. Jacinto R Hartung T McCall C Li L Lipopolysaccharideand lipoteichoic acid induced tolerance and cross-tolerance: Distinct alterations in il-1 receptor-associated kinase J Immunol 2002, 168:6136-6141. 12055225
79. Reddy RC Chen GH Tekchandani PK Standiford TJ Sepsis-induced immunosuppression: From bad to worse Immunol Res 2001, 24:273-287. 10.1385/IR:24:3:273 11817325